Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug Efflux

Multi-drug resistant tuberculosis (MDR-TB) represents a major health problem worldwide. Drug efflux and the activity of efflux transporters likely play important roles in the development of drug-tolerant and drug-resistant mycobacterial phenotypes. This study is focused on the action of a mycobacter...

Full description

Bibliographic Details
Main Authors: Barbara De Siena, Nicoletta Campolattano, Gianluca D’Abrosca, Luigi Russo, Daire Cantillon, Rosangela Marasco, Lidia Muscariello, Simon J. Waddell, Margherita Sacco
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2020.575828/full
_version_ 1818349697555759104
author Barbara De Siena
Nicoletta Campolattano
Gianluca D’Abrosca
Luigi Russo
Daire Cantillon
Rosangela Marasco
Lidia Muscariello
Simon J. Waddell
Margherita Sacco
author_facet Barbara De Siena
Nicoletta Campolattano
Gianluca D’Abrosca
Luigi Russo
Daire Cantillon
Rosangela Marasco
Lidia Muscariello
Simon J. Waddell
Margherita Sacco
author_sort Barbara De Siena
collection DOAJ
description Multi-drug resistant tuberculosis (MDR-TB) represents a major health problem worldwide. Drug efflux and the activity of efflux transporters likely play important roles in the development of drug-tolerant and drug-resistant mycobacterial phenotypes. This study is focused on the action of a mycobacterial efflux pump as a mechanism of drug resistance. Previous studies demonstrated up-regulation of the TetR-like transcriptional regulator MSMEG_3765 in Mycobacterium smegmatis and its ortholog Rv1685c in Mycobacterium tuberculosis (Mtb) in acid-nitrosative stress conditions. MSMEG-3765 regulates the expression of the MSMEG_3762/63/65 operon, and of the orthologous region in Mtb (Rv1687c/86c/85c). MSMEG-3762 and Rv1687c are annotated as ATP-binding proteins, while MSMEG-3763 and Rv1686c are annotated as trans-membrane polypeptides, defining an ABC efflux pump in both M. smegmatis and Mtb. The two putative efflux systems share a high percentage of identity. To examine the role of the putative efflux system MSMEG-3762/63, we constructed and characterized a MSMEG-3763 deletion mutant in M. smegmatis (∆MSMEG_3763). By comparative analysis of wild type, knockout, and complemented strains, together with structural modeling and molecular docking bioinformatics analyses of the MSMEG-3763 trans-membrane protein, we define the protein complex MSMEG-3762/63 as an efflux pump. Moreover, we demonstrate involvement of this pump in biofilm development and in the extrusion of rifampicin and ciprofloxacin (CIP), antimicrobial drugs used in first- and second-line anti-TB therapies.
first_indexed 2024-12-13T18:10:04Z
format Article
id doaj.art-f4407709c724465bb024ea2e121c693e
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-13T18:10:04Z
publishDate 2020-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-f4407709c724465bb024ea2e121c693e2022-12-21T23:35:58ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2020-12-011110.3389/fmicb.2020.575828575828Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug EffluxBarbara De Siena0Nicoletta Campolattano1Gianluca D’Abrosca2Luigi Russo3Daire Cantillon4Rosangela Marasco5Lidia Muscariello6Simon J. Waddell7Margherita Sacco8Dipartimento di Scienze e Tecnologie Ambientali Biologiche e Farmaceutiche, Università degli Studi della Campania Luigi Vanvitelli, Caserta, ItalyDipartimento di Scienze e Tecnologie Ambientali Biologiche e Farmaceutiche, Università degli Studi della Campania Luigi Vanvitelli, Caserta, ItalyDipartimento di Scienze e Tecnologie Ambientali Biologiche e Farmaceutiche, Università degli Studi della Campania Luigi Vanvitelli, Caserta, ItalyDipartimento di Scienze e Tecnologie Ambientali Biologiche e Farmaceutiche, Università degli Studi della Campania Luigi Vanvitelli, Caserta, ItalyDepartment of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, United KingdomDipartimento di Scienze e Tecnologie Ambientali Biologiche e Farmaceutiche, Università degli Studi della Campania Luigi Vanvitelli, Caserta, ItalyDipartimento di Scienze e Tecnologie Ambientali Biologiche e Farmaceutiche, Università degli Studi della Campania Luigi Vanvitelli, Caserta, ItalyDepartment of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, United KingdomDipartimento di Scienze e Tecnologie Ambientali Biologiche e Farmaceutiche, Università degli Studi della Campania Luigi Vanvitelli, Caserta, ItalyMulti-drug resistant tuberculosis (MDR-TB) represents a major health problem worldwide. Drug efflux and the activity of efflux transporters likely play important roles in the development of drug-tolerant and drug-resistant mycobacterial phenotypes. This study is focused on the action of a mycobacterial efflux pump as a mechanism of drug resistance. Previous studies demonstrated up-regulation of the TetR-like transcriptional regulator MSMEG_3765 in Mycobacterium smegmatis and its ortholog Rv1685c in Mycobacterium tuberculosis (Mtb) in acid-nitrosative stress conditions. MSMEG-3765 regulates the expression of the MSMEG_3762/63/65 operon, and of the orthologous region in Mtb (Rv1687c/86c/85c). MSMEG-3762 and Rv1687c are annotated as ATP-binding proteins, while MSMEG-3763 and Rv1686c are annotated as trans-membrane polypeptides, defining an ABC efflux pump in both M. smegmatis and Mtb. The two putative efflux systems share a high percentage of identity. To examine the role of the putative efflux system MSMEG-3762/63, we constructed and characterized a MSMEG-3763 deletion mutant in M. smegmatis (∆MSMEG_3763). By comparative analysis of wild type, knockout, and complemented strains, together with structural modeling and molecular docking bioinformatics analyses of the MSMEG-3763 trans-membrane protein, we define the protein complex MSMEG-3762/63 as an efflux pump. Moreover, we demonstrate involvement of this pump in biofilm development and in the extrusion of rifampicin and ciprofloxacin (CIP), antimicrobial drugs used in first- and second-line anti-TB therapies.https://www.frontiersin.org/articles/10.3389/fmicb.2020.575828/fullmycobacteriaefflux pumpantimicrobial drugsmulti drug resistancebiofilmtransmembrane protein
spellingShingle Barbara De Siena
Nicoletta Campolattano
Gianluca D’Abrosca
Luigi Russo
Daire Cantillon
Rosangela Marasco
Lidia Muscariello
Simon J. Waddell
Margherita Sacco
Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug Efflux
Frontiers in Microbiology
mycobacteria
efflux pump
antimicrobial drugs
multi drug resistance
biofilm
transmembrane protein
title Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug Efflux
title_full Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug Efflux
title_fullStr Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug Efflux
title_full_unstemmed Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug Efflux
title_short Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug Efflux
title_sort characterization of the mycobacterial msmeg 3762 63 efflux pump in mycobacterium smegmatis drug efflux
topic mycobacteria
efflux pump
antimicrobial drugs
multi drug resistance
biofilm
transmembrane protein
url https://www.frontiersin.org/articles/10.3389/fmicb.2020.575828/full
work_keys_str_mv AT barbaradesiena characterizationofthemycobacterialmsmeg376263effluxpumpinmycobacteriumsmegmatisdrugefflux
AT nicolettacampolattano characterizationofthemycobacterialmsmeg376263effluxpumpinmycobacteriumsmegmatisdrugefflux
AT gianlucadabrosca characterizationofthemycobacterialmsmeg376263effluxpumpinmycobacteriumsmegmatisdrugefflux
AT luigirusso characterizationofthemycobacterialmsmeg376263effluxpumpinmycobacteriumsmegmatisdrugefflux
AT dairecantillon characterizationofthemycobacterialmsmeg376263effluxpumpinmycobacteriumsmegmatisdrugefflux
AT rosangelamarasco characterizationofthemycobacterialmsmeg376263effluxpumpinmycobacteriumsmegmatisdrugefflux
AT lidiamuscariello characterizationofthemycobacterialmsmeg376263effluxpumpinmycobacteriumsmegmatisdrugefflux
AT simonjwaddell characterizationofthemycobacterialmsmeg376263effluxpumpinmycobacteriumsmegmatisdrugefflux
AT margheritasacco characterizationofthemycobacterialmsmeg376263effluxpumpinmycobacteriumsmegmatisdrugefflux